These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2813 related items for PubMed ID: 4628043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of hyperthermia on cell surface charge and cell survival in mastocytoma cells.
    Sato C, Nakayama T, Kojima K, Nishimoto Y, Nakamura W.
    Cancer Res; 1981 Oct; 41(10):4107-10. PubMed ID: 6793230
    [Abstract] [Full Text] [Related]

  • 8. Mast cell sarcoma: clinical management.
    Weiler CR, Butterfield J.
    Immunol Allergy Clin North Am; 2014 May; 34(2):423-32. PubMed ID: 24745684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A, Cairoli R, Morra E, Larizza L.
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.
    Gleixner KV, Rebuzzi L, Mayerhofer M, Gruze A, Hadzijusufovic E, Sonneck K, Vales A, Kneidinger M, Samorapoompichit P, Thaiwong T, Pickl WF, Yuzbasiyan-Gurkan V, Sillaber C, Willmann M, Valent P.
    Exp Hematol; 2007 Oct; 35(10):1510-21. PubMed ID: 17681669
    [Abstract] [Full Text] [Related]

  • 14. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK, Lindberg R, Ritter M, Nordlind K.
    J Comp Pathol; 2009 Oct; 141(2-3):89-97. PubMed ID: 19446835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Activity of proteolytic enzymes and their inhibitors in plasma of mice during tumor growth].
    Akbasheva OE, Sukhanova GA.
    Biull Eksp Biol Med; 1999 Jul; 128(7):69-72. PubMed ID: 10485056
    [No Abstract] [Full Text] [Related]

  • 18. Therapy of hematogenous melanoma brain metastases with endostatin.
    Kirsch M, Weigel P, Pinzer T, Carroll RS, Black PM, Schackert HK, Schackert G.
    Clin Cancer Res; 2005 Feb 01; 11(3):1259-67. PubMed ID: 15709197
    [Abstract] [Full Text] [Related]

  • 19. The elimination of i. v.-injected tumor cells. Studies with 125IUDR labelled cells in 4 syngeneic murine tumor systems.
    Ryd W, Hagmar B.
    Acta Pathol Microbiol Immunol Scand A; 1984 Jan 01; 92(1):23-30. PubMed ID: 6702457
    [Abstract] [Full Text] [Related]

  • 20. Mucosubstances in normal and in neoplastic mast cells of the dog.
    Mariano M.
    Acta Histochem; 1970 Jan 01; 36(1):14-23. PubMed ID: 4193856
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 141.